Second Quarter 2026
Filed Aug 10, 2026American Public Education Reports Second Quarter 2026 Financial Results; Completed Institutional Combination Subsequent to Quarter End and Raises Full Year 2026 Revenue, Net Income and Adjusted EBITDA Guidance
Second-quarter revenue grew 5.5%, both operating segments grew, net income available to common stockholders improved to $9.8 million from a loss of ($0.3) million, and adjusted EBITDA increased 36.8% to $20.7 million. Full-year 2026 revenue, net income, and adjusted EBITDA guidance was raised, although third-quarter guidance calls for lower net income and adjusted EBITDA than the Third Quarter 2025 comparison figures shown.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Consolidated revenueGAAP | $171.7 million | – | 5.5% |
| Consolidated revenue excluding Graduate School USA (GSUSA)other | >7.8% | – | 7.8% |
| Net income available to common stockholdersGAAP | $9.8 million | – | – |
| Adjusted EBITDAnon-GAAP | $20.7 million | – | 36.8% |
| Net income per diluted common shareGAAP | $0.52 | – | – |
| Cash flows from operationsGAAP | $12.1 million | – | – |
| Military+ Net Course Registrationsother | 98,300 | – | 2.0% |
| Health+ Total Student Enrollmentother | 19,600 | – | 6.6% |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Health+Primarily driven by increased enrollments and modest tuition increases. | $86.2 million | – | 11.0% |
| Military+Primarily driven by increased net course registrations. | $85.5 million | – | 4.7% |
Third Quarter and Full Year 2026 outlook
- RevenueThird Quarter 2026: $164.5 - $167.0; Full Year 2026: $690. 0 - $698.0
- NoteThird Quarter 2026 Military+ Net Registrations: 101,000-103,000; +1.0%-3.0% y/y
- NoteThird Quarter 2026 Health+ Enrollment: 19,100; +2.5% y/y
- NoteThird Quarter 2026 Net Income Available to Common Stockholders: $3.4 - $5.4
- NoteThird Quarter 2026 Adjusted EBITDA: $14.0 - $17.0
- NoteThird Quarter 2026 Diluted Earnings per Share: $0.18 - $0.29
- NoteFull Year 2026 Net Income Available to Common Stockholders: $46.5 - $52.5
- NoteFull Year 2026 Adjusted EBITDA: $96.0 - $104.0
- NoteFull Year 2026 Diluted Earnings per Share: $2.48 - $2.79 per share
- NoteFull Year 2026 Capital Expenditures: $25.0 - $28.0
Capital returns
- On March 10, 2026, the Board approved a common stock repurchase program of up to $50 million in the aggregate, replacing prior repurchase authorizations.
- During the three months ended June 30, 2026, the Company repurchased 70,365 shares of common stock.
- During the six months ended June 30, 2026, the Company repurchased 88,205 shares of common stock.
- As of June 30, 2026, there remains $45.0 million available under the share repurchase authorization.
What drove it
- Health+ revenue growth was primarily driven by increased enrollments and modest tuition increases.
- Military+ revenue growth was primarily driven by increased net course registrations.
- The Company cited continued demand across its businesses and disciplined execution against strategic priorities, including the opening of Health+’s new Orlando campus.
- Following quarter end, American Public University System, Rasmussen University, and Hondros College of Nursing were combined into one Higher Learning Commission-accredited institution named American Public University System.
Concerns
- Cash flows from operations were $12.1 million, compared to $14.8 million.
- Third Quarter 2026 net income available to common stockholders guidance of $3.4 - $5.4 is below the Third Quarter 2025 figure of $5.6.
- Third Quarter 2026 adjusted EBITDA guidance of $14.0 - $17.0 is below the Third Quarter 2025 figure of $20.7.
- Third Quarter 2026 diluted earnings per share guidance of $0.18 - $0.29 is below the Third Quarter 2025 figure of $0.30.
- The filing identifies risks related to regulatory and accrediting agency requirements, the 90/10 Rule, government shutdowns, government budget and federal workforce uncertainty, enrollment declines, Title IV and TA funding, and the institutional combination.
What to watch
- Third Quarter 2026 Military+ Net Registrations guidance of 101,000-103,000, compared to 100,000 in Third Quarter 2025.
- Third Quarter 2026 Health+ Enrollment guidance of 19,100, compared to 18,600 in Third Quarter 2025.
- Delivery against Full Year 2026 revenue guidance of $690. 0 - $698.0, including $8.0 of GSUSA Revenue in Full Year 2025.
- Delivery against Full Year 2026 adjusted EBITDA guidance of $96.0 - $104.0 and capital expenditures guidance of $25.0 - $28.0.
- Execution and expected benefits of the completed combination into one Higher Learning Commission-accredited institution.
Balance sheet and cash flow
- Total cash, cash equivalents, restricted cash and short-term investments were $222.8 million at June 30, 2026, compared to $176.5 million at December 31, 2025.
- Total cash, cash equivalents, restricted cash and short-term investments increased by $46.3 million, or 26.2%.
- Cash flows from operations were $12.1 million, compared to $14.8 million.
Analysis
APEI reported a solid second quarter, with consolidated revenue of $171.7 million, a 5.5% year-over-year increase from $162.8 million. The company said revenue would have increased 7.8% excluding Graduate School USA, which was sold in July 2025. Profitability improved materially: net income available to common stockholders was $9.8 million versus a loss of ($0.3) million, diluted earnings per share was $0.52 versus a loss of ($0.02), and adjusted EBITDA increased 36.8% to $20.7 million from $15.1 million.
Both operating segments contributed to growth. Health+ revenue increased 11.0% to $86.2 million, driven primarily by increased enrollments and modest tuition increases. Health+ total student enrollment was 19,600, compared with 18,300, a 6.6% increase. Military+ revenue increased 4.7% to $85.5 million, primarily driven by increased net course registrations; net course registrations were 98,300 compared with 96,400, a 2.0% increase.
Liquidity increased, with total cash, cash equivalents, restricted cash and short-term investments of $222.8 million at June 30, 2026, compared with $176.5 million at December 31, 2025. The company repurchased 70,365 shares during the three months ended June 30, 2026, and had $45.0 million remaining under its authorization. Cash flows from operations were $12.1 million, compared with $14.8 million, making cash conversion an important item to monitor alongside the stronger earnings measures.
Management raised full-year 2026 revenue, net income, and adjusted EBITDA guidance, with full-year revenue guided to $690. 0 - $698.0, net income available to common stockholders to $46.5 - $52.5, and adjusted EBITDA to $96.0 - $104.0. Nearer-term guidance is more subdued on profitability, as Third Quarter 2026 net income, adjusted EBITDA, and diluted earnings per share guidance are below the respective Third Quarter 2025 comparison figures provided. The company also completed the combination of American Public University System, Rasmussen University, and Hondros College of Nursing into one Higher Learning Commission-accredited institution subsequent to quarter end, placing execution of that combination alongside enrollment trends and third-quarter profitability at the center of the next update.
Management, verbatim
I am pleased with the strong financial results we delivered in the second quarter, reflecting continued demand across our businesses and disciplined execution against our strategic priorities, including the opening of Health+’s new Orlando campus, part of our “Trailblazer” campus opening strategy.
Angela Selden, President and Chief Executive Officer
As we raise revenue, net income and adjusted EBITDA guidance for 2026, we remain focused on disciplined execution and building on the momentum established in the first half of the year.
Angela Selden, President and Chief Executive Officer
Not in the filing
stated, not guessed- GAAP gross profit, gross margin, operating income, operating margin, and operating expenses were not provided in the supplied filing text.
- Free cash flow was not provided.
- Debt balances were not provided.
- Dividend payments or dividend declarations were not provided.
- Prior-quarter figures and quarter-over-quarter changes for reported second-quarter metrics were not provided.
- Prior-year percentage changes for net income available to common stockholders, diluted earnings per share, and cash flows from operations were not provided.
- Segment operating income, segment EBITDA, and segment margins were referenced as non-GAAP measures but their figures were not included in the supplied filing text.
- Prior outlook was not provided, so the magnitude of the stated guidance increases and comparisons of actual results with prior guidance cannot be determined.
- Forward guidance for gross margin, operating expenses, and tax rate was not provided.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.